Bares Capital Management’s Merck MRK Stock Holding History

Bares Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-3,976	Closed	-$215K	–	31
2014 Q4	$215K	Hold	3,976	–	–	0.03%	50
2014 Q3	$225K	Hold	3,976	–	–	0.03%	50
2014 Q2	$219K	Hold	3,976	–	–	0.02%	62
2014 Q1	$215K	Buy	+3,976	New	+$206K	0.02%	67

Other funds holding MRK

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bares Capital Management's MRK Position: Q1 2015 in Review

Bares Capital Management sold out of Merck (MRK) in Q1 2015, closing a stake of 3,976 shares — an estimated $215K sold.

Bares Capital Management first reported a position in MRK in Q1 2014 and held it in 4 quarters. The position peaked at $225K in Q3 2014. 1,711 funds tracked by Wall St. Rank hold MRK as of Q1 2015.

Bares Capital Management reported no remaining Merck position as of Q1 2015 after selling out during the quarter.
Bares Capital Management sold 3,976 Merck shares in Q1 2015, an estimated $215K.
Bares Capital Management first reported a position in Merck in Q1 2014 and held it in 4 quarters.
Bares Capital Management's Merck position peaked at $225K in Q3 2014.
1,711 funds tracked by Wall St. Rank held Merck as of Q1 2015.

Based on Bares Capital Management's 13F filing for Q1 2015, filed 15 May 2015.